Literature DB >> 17136023

Brief report: respiratory syncytial virus activity--United States, 2005-2006.

.   

Abstract

Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections (LRTIs) (e.g., bronchiolitis and pneumonia) among young children in the United States. RSV also causes severe respiratory disease and a substantial number of deaths among older adults and persons with compromised respiratory, cardiac, or immune systems. RSV is transmitted person to person through close contact or inhalation of large droplets from a sneeze or cough; infection also can occur through contact with fomites (i.e., contaminated surfaces or objects). In temperate climates, peak RSV activity typically occurs during the winter. This report presents preliminary data on RSV activity reported to the National Respiratory and Enteric Virus Surveillance System (NREVSS) for the weeks ending July 8-November 18, 2006, indicating the onset of the 2006-2007 RSV season, and summarizes RSV trends during July 2005-June 2006. Health-care providers should consider RSV in the differential diagnosis for persons of all ages with LRTIs and implement appropriate isolation precautions to prevent nosocomial transmission from RSV-infected patients. Immune prophylaxis should be considered for certain infants and young children at high risk for complications from RSV infection (e.g., certain premature infants or infants and children with chronic lung and heart disease).

Entities:  

Mesh:

Year:  2006        PMID: 17136023

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  9 in total

1.  Effect of young sibling visitation on respiratory syncytial virus activity in a NICU.

Authors:  A M Peluso; B A Harnish; N S Miller; E R Cooper; A M Fujii
Journal:  J Perinatol       Date:  2015-04-02       Impact factor: 2.521

2.  Attributable deaths due to influenza: a comparative study of seasonal and pandemic influenza.

Authors:  Monika Redlberger-Fritz; Judith Helene Aberle; Therese Popow-Kraupp; Michael Kundi
Journal:  Eur J Epidemiol       Date:  2012-06-08       Impact factor: 8.082

3.  Outcomes of palivizumab prophylaxis for respiratory syncytial virus infection in preterm children with bronchopulmonary dysplasia at a single hospital in Korea from 2005 to 2009.

Authors:  Seung Gu Chang; Moon Sung Park; Jae Eun Yu
Journal:  J Korean Med Sci       Date:  2010-01-19       Impact factor: 2.153

Review 4.  Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma.

Authors:  Shyam S Mohapatra; Sandhya Boyapalle
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

5.  Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity.

Authors:  Yueh-Ming Loo; Jamie Fornek; Nanette Crochet; Gagan Bajwa; Olivia Perwitasari; Luis Martinez-Sobrido; Shizuo Akira; Michelle A Gill; Adolfo García-Sastre; Michael G Katze; Michael Gale
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

6.  Epidemiology of respiratory syncytial virus in various regions within North Carolina during multiple seasons.

Authors:  David A Wilfret; Brent T Baker; Elizabeth Palavecino; Cassandra Moran; Daniel K Benjamin
Journal:  N C Med J       Date:  2008 Nov-Dec

7.  Diagnosis of respiratory syncytial virus infection.

Authors:  Therese Popow-Kraupp; Judith H Aberle
Journal:  Open Microbiol J       Date:  2011-12-30

8.  Investigation of the presence of human or bovine respiratory syncytial virus in the lungs of mink (Neovison vison) with hemorrhagic pneumonia due to Pseudomonas aeruginosa.

Authors:  Charlotte M Salomonsen; Solvej Ø Breum; Lars E Larsen; Jeanette Jakobsen; Niels Høiby; Anne S Hammer
Journal:  Acta Vet Scand       Date:  2012-11-26       Impact factor: 1.695

9.  Respiratory viral diseases: access to RNA interference therapy.

Authors:  Vira Bitko; Sailen Barik
Journal:  Drug Discov Today Ther Strateg       Date:  2007
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.